Charts Flashcards
DBLC LN pattern
- diffuse
acute lymphoblastic curable
- yes
ALL treatment
- combination chemo
acute lymphoblastic working formulation grade
- high
CML peripheral smear
- meyloid - left shifted - predominately mature
acute lymphoblastic cytogenetic abnormality
- none
Burkitt working formulation grade
- high
Burkitt curable
- yes
mantle cell immunostain
- cyclin D1
ALL adverse prognostic features
- Ph+ - age - t(4;11) - hypodiploidy
follicular immunostain
- BCL2
SLL LN pattern
- diffuse
CLL flow
- CD5/CD23
Burkitt LN pattern
- starry sky
mantle cell flow
- CD5+ - CD19+ - CD23- - clonal
CML flow
- no clonal lymphoid population
mantle cell cytogenetic abnormality
- t(11;14)
mantle cell LN pattern
- starry sky
APML cytogenetic abnormality
- t(15;17)
CLL adverse prognostic features
- cytogenetics - autoimmunity
ALL curable
- yes
ALL peripheral smear
- blasts
hodgkin immunostain
- CD15/CD30
follicular most diagnostic test
- flow - cytogenetics
Burkitt immunostain
- none
AML curable
- yes
CLL peripheral smear
- mature lymphoid cells - smudge cells
DBLC cytogenetic abnormality
- none
CLL curable
- no
follicular flow
- CD10+ - CD19+ - clonal
AML flow
- CD34+ - HLA-DR+
ALL flow
- CD34+ - CD10/19/Tdt
DBLC curable
- yes
AML treatment
- 7+3
hodgkin working formulation grade
- intermediate
burkitt most diagnostic test
- cytogenetics
SLL most diagnostic test
- flow
mantle cel curable
- no
SLL cytogenetic abnormality
- no
SLL curable
- no
Burkitt cytogenetic abnormality
- t(8;14) - t(2;8) - t(8;22)
CML treatment
- imatininb
mantle cell most diagnostic test
- flow - cytogenetics
AML adverse prognostic features
- Ph+ - age - arising from MDS or MPN or prior chemo - multiple cytogenetic abnormalities
APML flow
- CD 34 neg - HLA-DR neg - CD13+ - CD 33+
DLBC flow
- B cell markers - clonal
AMPL adverse prognostic features
- none
hodgkin cytogenetic abnormality
- none
AML peripheral smear
- blasts - Auer rods
acute lymphoblastic LN pattern
- diffuse
CML cytogenetic abnormality
- Philadelphia chromosome - t(9;22)
acute lymphoblastic flow
- CD4+ - CD8+
CML adverse prognostic features
- resistance to TKI
CLL cytogenetic abnormality
- no
acute lymphoblastic immunostain
- none
follicular cytogenetic abnormality
- t(14;18)
CLL treatment
- treat for symptoms
follicular curable
- no
SLL working formulation grade
- low
DBLC most diagnostic test
- flow - light microscopy - immunostain
CML curable
- yes
SLL immunostain
- none
SLL flow
- CD5+ - CD23+ - clonal
follicular LN pattern
- nodular
hodgkin flow
- non-clonal - non-diagnostic
mantle cell working formulation grade
- low and high
DBLC immunostain
- BCL6
AML cytogenetic abnormality
- no
hodgkin most diagnostic test
- immunostain
acute lymphoblastic most diagnostic test
- cytogenetics
APML curable
- yes
APML treatment
- ALTRA
Burkitt flow
- CD10+ - CD19+ - clonal
APML peripheral smear
- blasts - promyelocytes
Hodgkin LN pattern
- nodular with sclerosis
DBLC working formulation grade
- intermediate
hodgkin curable
- yes
follicular working formulation grade
- low
ALL cytogenetic abnormality
- no